僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Osocimab （BAY 1213790）, an anti-FXIa antibody （Ki=2.4 nM; EC50=0.2 nM）. FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects